Laurion Capital Management LP Athenex, Inc. Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$4.08 - $14.75 $1.96 Million - $7.1 Million	-481,193 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$11.06 - $14.01 $18,602 - $23,564	-1,682 Reduced 0.35%	481,193 $5.32 Million
Q3 2020 Nov 13, 2020	BUY	$10.26 - $14.55 $4.95 Million - $7.03 Million	482,875 New	482,875 $5.84 Million
Q4 2017 Feb 13, 2018	SELL	$14.41 - $19.15 $1.44 Million - $1.91 Million	-100,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$13.5 - $19.51 $1.35 Million - $1.95 Million	100,000	100,000 $1.75 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.